• ABOUT DRY EYE
  • Symptoms, Causes, and Diagnosis of Dry Eye
  • Treatments for Dry Eye
    • Artificial Tears
    • Prescription Options
    • Other Patient Options
• ABOUT LACRISERT^®
  • How LACRISERT^® Works
  • The Benefits of LACRISERT^®
  • Writing LACRISERT^®
  • How Patients Use LACRISERT^®
  • LACRISERT^® Efficacy Data
  • Patient Testimonials
• RESOURCES FOR YOU + YOUR PATIENTS
  • LACRISERT^® Sample Request and Material Order Form
  • Customizable Tip Sheet
  • Valeant Patient Savings Program
  • Valeant Patient Assistance Program
  • Learn More About LACRISERT^®
  • Valuable Links
  • Presentations
• FAQs

Valeant Patient Assistance Program

The Valeant Patient Assistance Program is a valuable service to help your patients access the medications they need by providing free or low-cost prescriptions for their Valeant products. Calling the Valeant Patient Assistance toll-free number, may provide them with:

• Information to help them learn how their medications will be reimbursed or covered by their health insurance
• Agents will uncover barriers to coverage, and what steps will be needed to overcome them
• Forms or instructions necessary for their coverage will be faxed or sent directly to your office
• Help on how to locate any insurance – including coverage they may not know they have or an older plan they may not know is still active
• Help in getting Valeant medications free of charge for patients who qualify, which requires that they:
• Are a legal resident of the US
• Do not have any known prescription drug coverage

Household Income for Eligible Patients*

If they have any questions about the coverage of LACRISERT^® by their insurance plan, they can call the toll-free hotline on 866-268-7325, Monday – Friday 9am–5pm (except holidays), to request forms or to speak to a knowledgeable Valeant representative.

Indications and Usage

LACRISERT^® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT^® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT^® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

LACRISERT^® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT^® should be carefully followed. If improperly placed, LACRISERT^® may result in corneal abrasion. Because LACRISERT^® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. Patients should be cautioned against rubbing the eye(s) containing LACRISERT^®.

The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.